News
Some types of PD-1 and PD-L1 inhibitors are available as subcutaneous injections that a cancer care professional injects into fat under the skin. These subcutaneous medications include ...
In this Healio Video Perspective, Michael A. Singer, MD, discusses promising results for migaldendranib for the treatment of ...
An oncology nurse shares advice for avoiding exhaustion and soreness when administering subcutaneous injections.
Vyvgart for subcutaneous injection is available as a vial or prefilled syringe and can be administered by a patient, caregiver, or healthcare professional. Treatment is initiated with a weekly dose ...
A new treatment option for people with multiple sclerosis could alleviate resource strains on New Zealand's health system.
1d
GlobalData on MSNFDA to review Otsuka’s sibeprenlimab application for IgANThe US Food and Drug Administration (FDA) has accepted Otsuka Pharmaceutical’s biologics licence application for ...
12d
Pharmaceutical Technology on MSNFDA approves Amneal’s DHE migraine/cluster headache autoinjectorThe US Food and Drug Administration has granted approval to Amneal Pharmaceuticals’ Brekiya (dihydroergotamine (DHE) mesylate ...
Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.
A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results